Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
March 28, 2024 08:15 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...